<DOC>
	<DOCNO>NCT00173628</DOCNO>
	<brief_summary>Evaluate autoantibody , glutamic acid decarboxylase ( GAD65 ) , tyrosine phosphatase ( IA-2 ICA125 ) , islet autoantibody ( IAA ) associate autoimmune autoantibody : microsomal antibody , thyroglobulin antibody , gastric parietal cell antibodies patient type 1 DM .</brief_summary>
	<brief_title>Autoantibodies Patients With Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>Type 1 diabetes mellitus ( DM ) common disease pediatric endocrine clinic epidemiological study show racial variation incidence , high 35 case per 100000 Finland . The incidence type 1 DM Taiwan report 1.5 per 100000 population less 30 year old . While diagnosis make , residual islet cell function 20 % normal population . Therefore , principle therapy patient insulin therapy lifelong . The pathogenesis type 1 diabetes mellitus multifactorial controversial , involve genetic environmental factor . Type 1 DM autoimmune disease , T cell mediate islet cell destruction . Ninety percent patient type 1 DM express least one autoantibodies islet . Antibodies glutamic acid decarboxylase 65 ( GAD65 ) observe 60-80 % patient , consider important autoantigens . The autoantibody disappear successively diagnosis decrease concentration time , titer antibody GAD65 observe fluctuated patient type 1 DM . The prevalence GAD antibody , insulin autoantibody , IA-2 ( tyrosine phosphatase ) report 45-67 % , 23-67 % 49 % , respectively Taiwan . Other associate autoimmune disease , autoimmune thyroiditis report 13-24 % . Such difference may cause enrol criterion different age population . Therefore , want elucidate role autoantibody pathogenesis type 1 DM .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>pediatric patient type 1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>August 2005</verification_date>
</DOC>